Psybio TherapeuticsPSYBF
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Psybio Therapeutics Corp. (PSYBF) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was AdvisorShares Investments LLC ($3).
- Company
- Psybio Therapeutics Corp.
- CUSIP
- 693697104
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| AdvisorShares Investments LLC | 0.00% | No change | 2,994,817 | $3 |
"% of holder's portfolio" is PSYBF's weight in each manager's 13F, not the share of Psybio Therapeutics Corp. the manager owns.